Status:

COMPLETED

Efficacy of Intravenous Iron Administration in Hemodialysis Patients

Lead Sponsor:

Kumamoto University

Conditions:

Chronic Renal Failure

Hemodialysis

Eligibility:

All Genders

18-90 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to determine whether the frequency of intravenous iron administration has an effect on anemia correction and oxidative stress formation in hemodialysis patients.

Detailed Description

In patients who are on chronic hemodialysis (HD), anemia is a major complication and is associated with poor clinical outcomes. Consequently, management of anemia by recombinant erythropoietin is repo...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of chronic renal failure
  • Clinical diagnosis of iron deficiency anemia
  • Must be on regular hemodialysis

Exclusion

  • Allergic to intravenous iron administration

Key Trial Info

Start Date :

June 1 2005

Trial Type :

INTERVENTIONAL

End Date :

March 1 2007

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00298441

Start Date

June 1 2005

End Date

March 1 2007

Last Update

May 12 2008

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Midorigaoka Clinic

Arao, Kumamoto, Japan, 864-0033

2

Kumamoto University Hospital

Kumamoto, Kumamoto, Japan, 860-8556

Efficacy of Intravenous Iron Administration in Hemodialysis Patients | DecenTrialz